Stay ahead of shifting statutory deadlines, new guidance documents, and international audit benchmarks.
A practical guide to classifying Class A, B, C, and D medical devices in India, avoiding common SUGAM portal pitfalls, and accelerating manufacturing (MD-5/MD-9) and import (MD-15) approvals.
How medical device manufacturers must structure Annex III Post-Market Surveillance plans, compile Periodic Safety Update Reports (PSUR), and integrate Clinical Evaluation Reports (CER) for Notified Bodies.
Analyzing the most frequent causes of FDA 510(k) intake rejections, demonstrating Substantial Equivalence (SE), and formatting compliant electronic eSTAR submissions for CDRH.
Step-by-step preparation for satisfying the quality system requirements of USA (FDA), Canada (Health Canada), Brazil (ANVISA), Japan (MHLW), and Australia (TGA) in a unified audit cycle.
Our senior regulatory directors in Ahmedabad provide tailored assessments for medical device companies preparing for submission or facing regulatory audits.
Book A 30-Minute Consultation
